ProQR Therapeutics N.V. Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes
ProQR Therapeutics N.V. (PRQR) reported Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes of -EUR 55.65 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges · last filed 2026-03-12
- ProQR Therapeutics N.V. increase decrease in cash and cash equivalents before effect of exchange rate changes for the quarter ending 2025-09-30 was -12.85M EUR, a 221.16% decline year-over-year.
- ProQR Therapeutics N.V. increase decrease in cash and cash equivalents before effect of exchange rate changes for the quarter ending 2025-06-30 was -11.79M EUR.
- ProQR Therapeutics N.V. increase decrease in cash and cash equivalents before effect of exchange rate changes for the quarter ending 2025-03-31 was -16.52M EUR.
- ProQR Therapeutics N.V. increase decrease in cash and cash equivalents before effect of exchange rate changes for the quarter ending 2024-09-30 was 10.60M EUR.
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 3 month | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 6 month | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 9 month | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month |
|---|---|---|---|---|
| 2025-12-31 | -55.65M EUR 20-F · filed 2026-03-12 | |||
| 2025-09-30 | -12.85M EUR 6-K · filed 2025-11-06 | -41.16M EUR 6-K · filed 2025-11-06 | ||
| 2025-06-30 | -11.79M EUR 6-K · filed 2025-08-07 | -28.32M EUR 6-K · filed 2025-08-07 | ||
| 2025-03-31 | -16.52M EUR 6-K · filed 2025-05-08 | |||
| 2024-12-31 | 29.81M EUR 20-F · filed 2026-03-12 | |||
| 2024-09-30 | 10.60M EUR 6-K · filed 2025-11-06 | -29.48M EUR 6-K · filed 2025-11-06 | ||
| 2024-06-30 | -6.80M EUR 6-K · filed 2025-08-07 | -40.09M EUR 6-K · filed 2025-08-07 | ||
| 2024-03-31 | -33.28M EUR 6-K · filed 2025-05-08 | |||
| 2023-12-31 | 23.55M EUR 20-F · filed 2026-03-12 | |||
| 2023-09-30 | -8.13M EUR 6-K · filed 2024-11-07 | 24.96M EUR 6-K · filed 2024-11-07 | ||
| 2023-06-30 | -11.28M EUR 6-K · filed 2024-08-08 | 33.09M EUR 6-K · filed 2024-08-08 | ||
| 2023-03-31 | 44.38M EUR 6-K · filed 2024-05-09 | |||
| 2022-12-31 | -100.10M EUR 20-F · filed 2025-03-13 | |||
| 2022-09-30 | -59.36M EUR 6-K · filed 2023-11-07 | -96.05M EUR 6-K · filed 2023-11-07 | ||
| 2022-06-30 | -15.43M EUR 6-K · filed 2023-08-03 | -36.69M EUR 6-K · filed 2023-08-03 | ||
| 2022-03-31 | -21.25M EUR 6-K · filed 2023-05-16 | |||
| 2021-12-31 | 30.56M EUR 6-K · filed 2022-02-24 | 110.39M EUR 20-F · filed 2024-03-13 | ||
| 2021-09-30 | 15.33M EUR 6-K · filed 2022-11-09 | 79.83M EUR 6-K · filed 2022-11-09 | ||
| 2021-06-30 | 73.31M EUR 6-K · filed 2022-08-04 | 64.50M EUR 6-K · filed 2022-08-04 | ||
| 2021-03-31 | -8.81M EUR 6-K · filed 2022-05-05 | |||
| 2020-12-31 | -11.68M EUR 6-K · filed 2022-02-24 | -33.48M EUR 20-F · filed 2023-03-29 | ||
| 2020-09-30 | 3.18M EUR 6-K · filed 2021-11-04 | -21.81M EUR 6-K · filed 2021-11-04 | ||
| 2020-06-30 | -10.34M EUR 6-K · filed 2021-08-05 | -24.99M EUR 6-K · filed 2021-08-05 | ||
| 2020-03-31 | -14.65M EUR 6-K · filed 2020-05-07 | |||
| 2019-12-31 | 38.01M EUR 6-K · filed 2021-02-25 | 5.65M EUR 20-F · filed 2022-04-29 | ||
| 2019-09-30 | -9.09M EUR 6-K · filed 2020-11-16 | -32.36M EUR 6-K · filed 2020-11-16 | ||
| 2019-06-30 | -11.16M EUR 6-K · filed 2020-08-06 | -23.27M EUR 6-K · filed 2020-08-06 | ||
| 2019-03-31 | -12.11M EUR 6-K · filed 2020-05-07 | |||
| 2018-12-31 | 57.65M EUR 20-F · filed 2021-03-24 | |||
| 2018-09-30 | 80.69M EUR 6-K · filed 2019-11-12 | 65.81M EUR 6-K · filed 2019-11-12 | ||
| 2018-06-30 | -5.47M EUR 6-K · filed 2019-08-07 | -14.88M EUR 6-K · filed 2019-08-07 | ||
| 2017-12-31 | -8.43M EUR 20-F · filed 2020-03-31 | |||
| 2017-06-30 | -8.72M EUR 6-K · filed 2018-08-08 | -15.40M EUR 6-K · filed 2018-08-08 | ||
| 2016-12-31 | -36.40M EUR 20-F · filed 2019-03-28 | |||
| 2015-12-31 | -23.94M EUR 20-F · filed 2018-03-30 |